Visit us at EHA

Oncopeptides presented clinical results from an ongoing Phase I/II study in patients with relapsed and relapsed refractory multiple myeloma in combination with dexamethasone at the European Hematology Association meeting in Vienna.

Upcoming events

Silent Period

-

Silent Period

-

Silent Period

-

Year-end report 2022

08:00 CET